Chronic Kidney Disease Stage

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2014-09-22
Clinical Trial Update: Four Week, Pharmacodynamic/Pharmacokinetic, Efficacy, and Safety Study of Lunacalcipol (CTA018) [Phase 2]
A Phase 2 trial of Lunacalcipol (CTA018) for chronic kidney disease stage 5 with secondary hyperparathyroidism has been withdrawn.